Cliff Asness’s Kite Pharma, Inc. KITE Stock Holding History

Cliff Asness’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-51,461	Closed	-$9.25M	–	2332
2017 Q3	$9.25M	Buy	51,461 +31,202	+154%	+$4.35M	0.01%	802
2017 Q2	$2.1M	Buy	+20,259	New	+$1.65M	﹤0.01%	1363
2016 Q4	–	Sell	-6,150	Closed	-$344K	–	2323
2016 Q3	$344K	Hold	6,150	–	–	﹤0.01%	2051
2016 Q2	$308K	Sell	6,150 -1,590	-21%	-$78.1K	﹤0.01%	2007
2016 Q1	$355K	Sell	7,740 -23,916	-76%	-$1.16M	﹤0.01%	1948
2015 Q4	$1.95M	Sell	31,656 -12,139	-28%	-$854K	﹤0.01%	1252
2015 Q3	$2.44M	Buy	43,795 +35,337	+418%	+$2.22M	﹤0.01%	1056
2015 Q2	$516K	Buy	+8,458	New	+$483K	﹤0.01%	1765

Cliff Asness's KITE Position: Q4 2017 in Review

Cliff Asness sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 51,461 shares — an estimated $9.25M sold.

Cliff Asness first reported a position in KITE in Q2 2015 and held it in 8 quarters. The position peaked at $9.25M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Cliff Asness reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Cliff Asness sold 51,461 Kite Pharma, Inc. shares in Q4 2017, an estimated $9.25M.
Cliff Asness first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 8 quarters.
Cliff Asness's Kite Pharma, Inc. position peaked at $9.25M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on AQR Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.